Trial Profile
A Randomized, Multiple-dose, Placebo- and Positive-controlled Parallel Group Study to Evaluate the Effects of Indacaterol on Cardiac Safety in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Dec 2010
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Moxifloxacin
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors Novartis Pharmaceuticals
- 25 Dec 2010 New trial record